Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-19

Clinical Trial Update: Low Sirtuin-1 Levels Are Linked to Erythropoietin Resistance in Hemodialysis Patients.

View source ↗

Summary

A completed clinical trial found that low Sirtuin-1 levels are linked to erythropoietin resistance in patients undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cuma Bulent Gul | Conditions: Chronic Kidney Disease, Hemodialysis | Status: COMPLETED